Motif Bio plc Warrants to Purchase ADRs
MTFBW
MTFBW was delisted on the 16th of December, 2019.
4 hedge funds and large institutions have $44K invested in Motif Bio plc Warrants to Purchase ADRs in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
70% less capital invested
Capital invested by funds: $147K → $44K (-$103K)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$179 |
MTFBW Hedge Fund Activity: Q2 2019 in Review
4 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Motif Bio plc Warrants to Purchase ADRs (MTFBW) for Q2 2019, worth a combined $44K — down 70% from $147K a quarter earlier.
Fund positioning in MTFBW was balanced in Q2 2019: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Wolverine Asset Management, cutting an estimated $179.
- 4 institutional investors held Motif Bio plc Warrants to Purchase ADRs (MTFBW) as of Q2 2019, unchanged from Q1 2019.
- Funds reported $44K of Motif Bio plc Warrants to Purchase ADRs stock for Q2 2019, down 70% quarter-over-quarter.
- 0 funds opened new Motif Bio plc Warrants to Purchase ADRs positions in Q2 2019 and 0 closed out.
- The largest Motif Bio plc Warrants to Purchase ADRs seller in Q2 2019 was Wolverine Asset Management, an estimated $179 sold.
Based on aggregated 13F filings for Q2 2019.